281 related articles for article (PubMed ID: 15335355)
41. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
42. TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients.
Lin L; Nonoyama S; Oshiba A; Kabasawa Y; Mizutani S
J Med Dent Sci; 2003 Mar; 50(1):27-33. PubMed ID: 12715916
[TBL] [Abstract][Full Text] [Related]
43. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes.
Kanda N; Mitsui H; Watanabe S
J Allergy Clin Immunol; 2004 Dec; 114(6):1403-9. PubMed ID: 15577845
[TBL] [Abstract][Full Text] [Related]
44. Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-13, TNF-alpha and IFN-gamma in human keratinocyte and fibroblast.
Yu B; Koga T; Urabe K; Moroi Y; Maeda S; Yanagihara Y; Furue M
J Dermatol Sci; 2002 Oct; 30(1):29-36. PubMed ID: 12354417
[TBL] [Abstract][Full Text] [Related]
45. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis.
Morita E; Hiragun T; Mihara S; Kaneko S; Matsuo H; Zhang Y; Dekio S
J Dermatol Sci; 2004 May; 34(3):237-40. PubMed ID: 15113595
[TBL] [Abstract][Full Text] [Related]
46. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
[TBL] [Abstract][Full Text] [Related]
47. Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 3-O-β-D-glucopyanosylspinasterol via blocking NF-κB and STAT1 signaling pathways in TNF-α and IFN-γ-induced HaCaT keratinocytes.
Jung MR; Lee TH; Bang MH; Kim H; Son Y; Chung DK; Kim J
Biochem Biophys Res Commun; 2012 Oct; 427(2):236-41. PubMed ID: 22943853
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Ishida T; Utsunomiya A; Iida S; Inagaki H; Takatsuka Y; Kusumoto S; Takeuchi G; Shimizu S; Ito M; Komatsu H; Wakita A; Eimoto T; Matsushima K; Ueda R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3625-34. PubMed ID: 14506150
[TBL] [Abstract][Full Text] [Related]
49. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics.
Panina-Bordignon P; Papi A; Mariani M; Di Lucia P; Casoni G; Bellettato C; Buonsanti C; Miotto D; Mapp C; Villa A; Arrigoni G; Fabbri LM; Sinigaglia F
J Clin Invest; 2001 Jun; 107(11):1357-64. PubMed ID: 11390417
[TBL] [Abstract][Full Text] [Related]
50. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
[TBL] [Abstract][Full Text] [Related]
51. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
[TBL] [Abstract][Full Text] [Related]
52. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions.
Vestergaard C; Yoneyama H; Murai M; Nakamura K; Tamaki K; Terashima Y; Imai T; Yoshie O; Irimura T; Mizutani H; Matsushima K
J Clin Invest; 1999 Oct; 104(8):1097-105. PubMed ID: 10525048
[TBL] [Abstract][Full Text] [Related]
53. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.
Homey B; Alenius H; Müller A; Soto H; Bowman EP; Yuan W; McEvoy L; Lauerma AI; Assmann T; Bünemann E; Lehto M; Wolff H; Yen D; Marxhausen H; To W; Sedgwick J; Ruzicka T; Lehmann P; Zlotnik A
Nat Med; 2002 Feb; 8(2):157-65. PubMed ID: 11821900
[TBL] [Abstract][Full Text] [Related]
54. Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced TARC activation in HaCaT cells.
Choi JH; Jin SW; Park BH; Kim HG; Khanal T; Han HJ; Hwang YP; Choi JM; Chung YC; Hwang SK; Jeong TC; Jeong HG
Food Chem Toxicol; 2013 Jun; 56():195-203. PubMed ID: 23454147
[TBL] [Abstract][Full Text] [Related]
55. Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes.
Jeong SI; Choi BM; Jang SI
Arch Pharm Res; 2010 Nov; 33(11):1867-76. PubMed ID: 21116791
[TBL] [Abstract][Full Text] [Related]
56. Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes.
Shoda T; Futamura K; Kobayashi F; Saito H; Matsumoto K; Matsuda A
J Dermatol Sci; 2014 Nov; 76(2):90-5. PubMed ID: 25219597
[TBL] [Abstract][Full Text] [Related]
57. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
[TBL] [Abstract][Full Text] [Related]
58. Glucocorticoid-induced tumour necrosis factor receptor (GITR) and its ligand (GITRL) in atopic dermatitis.
Baumgartner-Nielsen J; Vestergaard C; Thestrup-Pedersen K; Deleuran M; Deleuran B
Acta Derm Venereol; 2006; 86(5):393-8. PubMed ID: 16955181
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
60. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
